OneMedNet Corp Files Q3 2024 10-Q
Ticker: ONMDW · Form: 10-Q · Filed: Dec 17, 2024 · CIK: 1849380
Sentiment: neutral
Topics: 10-Q, financials, revenue
Related Tickers: ONMD
TL;DR
OneMedNet's Q3 10-Q is in: check subscription and web imaging revenue for ONMD.
AI Summary
OneMedNet Corp filed its 10-Q for the period ending September 30, 2024. The company, formerly known as Data Knights Acquisition Corp., reported financial results for the third quarter and the first nine months of the year. Specific revenue figures for subscription and web imaging services were detailed for the relevant periods.
Why It Matters
This filing provides investors with the latest financial performance data for OneMedNet Corp, crucial for understanding the company's operational health and future prospects.
Risk Assessment
Risk Level: medium — The filing is a standard quarterly report, but the company's specific financial performance and industry position could present inherent risks.
Key Numbers
- Q3 2024 — Reporting Period (Third quarter financial results)
- First Nine Months of 2024 — Reporting Period (Year-to-date financial results)
Key Players & Entities
- OneMedNet Corp (company) — Filer of the 10-Q
- Data Knights Acquisition Corp. (company) — Former name of OneMedNet Corp
- 20240930 (date) — End of the reporting period
- 20241217 (date) — Filing date
FAQ
What were OneMedNet Corp's subscription revenues for Q3 2024?
The filing indicates subscription revenue for the period July 1, 2024 to September 30, 2024, but the specific dollar amount is not provided in this header data.
How did web imaging revenues compare between Q3 2024 and Q3 2023?
The filing lists web imaging revenue for both periods (July 1, 2024 - September 30, 2024 and July 1, 2023 - September 30, 2023), but specific figures are not detailed in this header.
What is OneMedNet Corp's fiscal year end?
OneMedNet Corp's fiscal year ends on December 31.
When did the company change its name from Data Knights Acquisition Corp.?
The company changed its name from Data Knights Acquisition Corp. on March 4, 2021.
What is the exercise price for OneMedNet's redeemable warrants?
The redeemable warrants are exercisable for one share of common stock at an exercise price of $11.50 per share.
Filing Stats: 4,642 words · 19 min read · ~15 pages · Grade level 18.7 · Accepted 2024-12-17 17:25:11
Key Financial Figures
- $0.0001 — ch registered Common stock, par value $0.0001 per share ONMD The Nasdaq Stock Mar
- $11.50 — of Common Stock at an exercise price of $11.50 per share ONMDW The Nasdaq Stock Ma
Filing Documents
- form10-q.htm (10-Q) — 1071KB
- ex10-8.htm (EX-10.8) — 71KB
- ex31-1.htm (EX-31.1) — 17KB
- ex31-2.htm (EX-31.2) — 17KB
- ex32-1.htm (EX-32.1) — 8KB
- ex32-2.htm (EX-32.2) — 8KB
- 0001493152-24-050454.txt ( ) — 5591KB
- onmd-20240930.xsd (EX-101.SCH) — 42KB
- onmd-20240930_cal.xml (EX-101.CAL) — 53KB
- onmd-20240930_def.xml (EX-101.DEF) — 221KB
- onmd-20240930_lab.xml (EX-101.LAB) — 377KB
- onmd-20240930_pre.xml (EX-101.PRE) — 308KB
- form10-q_htm.xml (XML) — 725KB
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 16 Item 3.
Quantitative and Qualitative Disclosures About Market Risk
Quantitative and Qualitative Disclosures About Market Risk 24 Item 4.
Controls and Procedures
Controls and Procedures 24 PART II. OTHER INFORMATION 25 Item 1.
Legal Proceedings
Legal Proceedings 25 Item 1A.
Risk Factors
Risk Factors 25 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 25 Item 3. Defaults Upon Senior Securities 25 Item 4. Mine Safety Disclosures 25 Item 5. Other Information 25 Item 6. Exhibits 25
Signatures
Signatures 26 i CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS Certain constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, and of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). All statements other than statements of historical facts contained in this Form 10-Q are forward-looking statements. The forward-looking statements in this Form 10-Q are only predictions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition, and results of operations. In some cases, you can identify these forward-looking statements by terms such as "anticipate," "believe," "continue," "could," "depends," "estimate," "expects," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would" or the negative of those terms or other similar expressions, although not all forward-looking statements contain those words. We have based these forward-looking results of operations, strategy, short- and long-term business operations and objectives, and financial needs. Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. We have based these forward-looking statements largely on our current expectations and projections about future events and trends that we believe may